Literature DB >> 9079619

Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption.

T Inui1, O Ishibashi, T Inaoka, Y Origane, M Kumegawa, T Kokubo, T Yamamura.   

Abstract

Cathepsin K is a recently identified cysteine protease which is abundantly and selectively expressed in osteoclasts. To evaluate the contribution of cathepsin K to bone resorption processes, we investigated the effect of cathepsin K antisense phosphothiorate oligodeoxynucleotide (S-ODN) on the bone-resorbing activity of osteoclasts. Rabbit osteoclasts were cultured on dentine slices for 24 h in the presence or absence of antisense S-ODN in a medium containing 100 nM TfxTM-50, polycationic liposome, as a carrier of the S-ODN. Uptake of the S-ODN by osteoclasts was confirmed microscopically using fluorescein-labeled S-ODN. The treatment with antisense significantly decreased the amount of cathepsin K protein in osteoclasts. The antisense inhibited the osteoclastic pit formation in a concentration-dependent fashion. At 10 microM the antisense reduced the total pit number and area and average pit depth by 46, 52, and 30%, respectively. The sense and mismatch S-ODNs, which were used as negative controls, had no effect on either the cathepsin K protein level or the pit formation. A nonspecific cysteine protease inhibitor, E-64, also reduced pit formation in a concentration-dependent manner with maximum reductions at 1 microM of 46, 48, and 35% in the above pit parameters. The inhibitory effect of the antisense almost equal to that of E-64 demonstrates that cathepsin K is a cysteine protease playing a crucial role in osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079619     DOI: 10.1074/jbc.272.13.8109

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

2.  Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor alpha.

Authors:  H Mano; Y Hakeda; M Kumegawa
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

3.  A Proposal for the Evolution of Cathepsin and Silicatein in Sponges.

Authors:  Ana Riesgo; Manuel Maldonado; Susanna López-Legentil; Gonzalo Giribet
Journal:  J Mol Evol       Date:  2015-05-19       Impact factor: 2.395

4.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Authors:  Izabela Podgorski; Bruce E Linebaugh; Mansoureh Sameni; Christopher Jedeszko; Sunita Bhagat; Michael L Cher; Bonnie F Sloane
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

5.  Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.

Authors:  Makoto Tanaka; Akihiro Hosoya; Hiroshi Mori; Ryoji Kayasuga; Hiroaki Nakamura; Hidehiro Ozawa
Journal:  J Bone Miner Metab       Date:  2017-02-27       Impact factor: 2.626

6.  IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

Authors:  S Kamolmatyakul; W Chen; S Yang; Y Abe; R Moroi; A M Ashique; Y-P Li
Journal:  J Dent Res       Date:  2004-10       Impact factor: 6.116

7.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.

Authors:  Michael L Cher; Hector R Biliran; Sunita Bhagat; Yonghong Meng; Mingxin Che; Jaron Lockett; Judith Abrams; Rafael Fridman; Michael Zachareas; Shijie Sheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

8.  Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.

Authors:  Amy Tomita; Tatsuhiko Kasaoka; Takashi Inui; Minako Toyoshima; Hiroko Nishiyama; Hiromasa Saiki; Haruo Iguchi; Motowo Nakajima
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

9.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.

Authors:  P Saftig; E Hunziker; O Wehmeyer; S Jones; A Boyde; W Rommerskirch; J D Moritz; P Schu; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.

Authors:  Hubert Marotte; Pierre Miossec
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.